The International Osteoporosis Foundation (IOF)
Actualités sur Medizin, Gesundheit
- plus
Investigational, Once-weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-daily Insulin Glargine U100 in Phase 2 Trial
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only, excl US For journalistic assessment and preparation before publication. Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analogue. In the ...
plusSwitching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only, excl US. For journalistic assessment and preparation before publication. - A separate real-world study showed that people with type 2 diabetes on two oral antidiabetic drugs who intensified with a glucagon-like peptide-1 ...
plusInternational Atherosclerosis Society
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk
Milan (ots/PRNewswire) - Article and slides can be found at https://www.athero.org/activities/survey or contact Karen Foy (karen.foy@athero.org) A new survey by the International Atherosclerosis Society (IAS) provided a 'snapshot' of the gaps in knowledge among clinicians that limit best practice. This web-based ...
plusGalderma Global Research Reveals Struggles of People With Rosacea and Psoriasis of the Face Experiencing a Lack of Control and Impact on Mental Wellbeing
Lausanne, Switzerland (ots/PRNewswire) - Healthcare professionals (HCPs) encouraged to investigate true impacts beyond the visible, empower patients with knowledge and aim for 'clear' (IGA 0) skin to improve outcomes A new expert-authored Galderma report (https://hosted.bmj.com/rosaceabeyondthevisible) released ...
plusDebiopharm's Novel Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders
Lausanne, Switzerland (ots) - Takeda will pursue the development of a novel preclinical narrow spectrum microbiome remodeling program, to treat diseases related to dysbiosis of the human gut microbiome Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today an exclusive license agreement ...
plus
Debiopharm partners with Verity Pharmaceuticals for the exclusive US commercialization of Trelstar® for Prostate Cancer
LAUSANNE, SWITZERLAND & WAYNE, PENNSYLVANIA (ots) - Debiopharm, a Swiss-based, biopharmaceutical company, and Verity Pharmaceuticals Inc., a US based specialty pharmaceutical company focused on therapeutic solutions for genitourinary (GU) diseases, today announced having entered into an exclusive agreement that ...
plusFirst Adjuvanted Quadrivalent Influenza Vaccine by Seqirus Receives EU Approval
Maidenhead, England (ots/PRNewswire) - The European Commission has today given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become available across Europe. This new vaccine builds on the well-established technology used in an existing adjuvanted trivalent influenza vaccine (aTIV) available in several European countries. aTIV has ...
plusUCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
Brussels, Belgium (ots/PRNewswire) - - Underlines UCB's leadership in epilepsy by adding Staccato® Alprazolam, a drug-device-combination with the potential to be the first on-demand, single-use treatment to rapidly terminate an active epileptic seizure - Staccato® Alprazolam could be a potential solution for ...
plusAvectas and UC Davis Collaborate on Cell Engineering Technology
Dublin (ots/PRNewswire) - Collaboration will advance Avectas' cell engineering technology leveraging UC Davis' world-class cell membrane characterisation expertise Avectas today announced that it has entered into a collaborative agreement with The Simon Laboratory at UC Davis, California, USA (UCD) to engage in the characterisation of cells engineered with Avectas' proprietary, non-viral SOLUPORE(TM) cell engineering ...
plusZentiva Expands Production Capacity by Completing Acquisition of Ankleshwar Manufacturing Site
Prague (ots/PRNewswire) - Zentiva Group announces the completion of its acquisition of a manufacturing site in Ankleshwar, India, from Sanofi. The finalization of the deal increases the number of wholly-owned Zentiva production sites worldwide and will enable Zentiva to serve more people who are in daily need of our high quality, affordable medicines. "We are delighted ...
plusMerck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS
Darmstadt, Germany (ots/PRNewswire) - - Merck and Twitch collaborate on World MS Day to increase understanding of the impact of multiple sclerosis (MS) - Livestream event with Twitch influencers on May 30 will raise awareness and money for the MS International Federation and help connect people affected by the disease, in line with official World MS Day theme MS ...
plus
China Matters and Tianjin Haihe Media Group Released Co-produced Documentary "A Man on a Rescue Mission against COVID-19"
Tianjin, China (ots/PRNewswire) - At the age of 72, Zhang Boli, a medical professional from Tianjin, was saving lives at the forefront of the COVID-19 response in Wuhan while being saved by others. Doctor Zhang was convinced that traditional Chinese medicine (TCM) could be helpful alongside Western medicine for ...
plusChina Matters and Tianjin Haihe Media Group Released Co-produced Documentary "Everyday Warriors in Tianjin's Fight Against COVID-19"
Tianjin, China (ots/PRNewswire) - Among the unsung characters in the fight against COVID-19, Qu Lei is the only sign-language interpreter for Tianjin's Press Conference on the pandemic prevention and control. From February 8, Qu was gesturing the latest information of the pandemic to the hearing-impaired audience, ...
plusChina Matters and Tianjin Haihe Media Group Released Co-produced Documentary "A Port City's Quick Response to COVID-19"
Tianjin, China (ots/PRNewswire) - Tianjin's public health emergency response level was lowered to level-2 on April 30, after almost four months of continuous efforts in COVID-19 prevention and control. As a port city, Tianjin faced drastic challenges during the pandemic. On January 25, Costa Serena, a cruise ship ...
plusDERMALOG Identification Systems GmbH
DERMALOG Fever Check at German Baltic Hotel
Usedom and Hamburg, Germany (ots/PRNewswire) - - Picture is available at AP Images ( http://www.apimages.com/ ) - In the course of the Corona pandemic, the hospitality industry has come under increased scrutiny by public authorities. Incidents such as the Covid-19 outbreak in the Austrian town of Ischgl have led to extensive regulations for the safe operation of hotels and restaurants. At the same time, owners are ...
plusSMART Medical Systems Receives FDA Clearance for Its G-EYE® Colonoscope
Ra'anana, Israel (ots/PRNewswire) - SMART's G-EYE®Colonoscope, incorporating the G-EYE® Balloon Technology which helps control the endoscope's field of view and positioning during colonoscopy, was cleared for marketing in the USA by FDA SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced that the FDA issued 510(k) ...
plusAcquisition of Debiopharm's investment portfolio company Kaiku Health broadens patient access to digital oncology intervention
Lausanne, Switzerland (ots) - - Debiopharm announces successful exit deal for Kaiku Health, a Finnish start-up specializing in digital solutions for improved patient outcomes and experience - Kaiku's acquisition by the Swedish company Elekta allows thousands of cancer treatment centers to gain access to the ...
plus
WSSCC Names New Executive Director
plusThe Global Center on Adaptation
African Leaders Endorse Plan From Global Center on Adaptation for Africa to Build Climate Resilience Into Recovery From COVID-19 Pandemic
Rotterdam, Netherlands (ots/PRNewswire) - Today, 54 leaders from the African Adaptation Initiative championed by President Ali Bongo Ondimba of Gabon, endorsed the policy recommendations outlined in the brief "Integrated Responses to Building Climate and Pandemic Resilience in Africa". The policy brief was prepared ...
plusTauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
Aberdeen, Scotland and Singapore (ots/PRNewswire) - Minimum dose of hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia as well as Alzheimer's Disease In a paper published online in the Journal of Alzheimer's Disease ( https://doi.org/10.3233/JAD-191173 ) , TauRx reported that the drug it is developing for ...
plusSchweizerischer Nationalfonds / Fonds national suisse
The SNSF funds 36 new coronavirus research projects
Bern (ots) - Under the special call on coronaviruses, the societal and biomedical aspects of epidemics will be investigated with a total budget of 10 million francs. The projects will start as of 1 June 2020. As the coronavirus pandemic began to take hold, the SNSF took swift action by launching a special call on coronaviruses on 6 March 2020. The call was enthusiastically received in the research community. - ...
plusThe Belgian Start-up the Medical Cloud Company (MedC2), Supported by 860,000 Euros From the European Commission to Develop Tools Supporting Decision Making for Citizens and Doctors in the COVID-19 Crisis
Liège, Belgium (ots/PRNewswire) - MedC2, a startup focusing on digital health, has received this week the approval from the European Commission for a 860,000 euros subsidy as part of the launch of the international project DRAGON ( link ...
plusBreakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
Darmstadt, Germany (ots/PRNewswire) - - Results from two studies of BAVENCIO® to be featured in ASCO press briefing - Primary efficacy, biomarker and HRQoL analyses for tepotinib?, the first MET inhibitor to have received a regulatory approval for NSCLC with MET gene alterations - Two-year follow-up for first-in-class bifunctional immunotherapy bintrafusp alfa? ...
plus
Dpt of Precision Medicine, Maastricht University
The Department of Precision Medicine of Maastricht University Receives 920KEUR from the European Commission to Further Develop Their Work on Artificial Intelligence Tools for COVID-19 Patients
Maastricht, Netherlands (ots/PRNewswire) - The D (http://dnamito.com/) epartment of Precision Medicine (http://dnamito.com/) at (http://dnamito.com/) Maastricht University (http://dnamito.com/) (The Netherlands) announced today the release of their AI tool for COVID-19 patient triage, the same week that they ...
plusNEOVII Partners with Tel Aviv University to Develop Novel COVID-19 Vaccine
Rapperswil, Switzerland and Tel Aviv, Israel (ots/PRNewswire) - The epitope-based vaccine will target the most vulnerable part of the viral spike protein Ramot , Tel Aviv University's technology transfer company, and Neovii , a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license ...
plusNEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With Tel Aviv University
Rapperswil, Switzerland (ots/PRNewswire) - Neovii, the Swiss-based biopharmaceutical company and a member of Israeli-based Neopharm Group, has signed a research and license agreement with Tel Aviv University's (TAU) RAMOT, its technology transfer company, to work in collaboration with a team led by Professor ...
plusEuro Airport Basel-Mulhouse-Freiburg
EuroAirport prepares for the return of passengers - protective masks mandatory on airport premises
EuroAirport prepares for the return of passengers – protective masks mandatory on airport premises After both France and Switzerland announced an easing of ...
Un documentplusValidation and Reliability of COVID-19 Rapid Test BIOZEK
Apeldoorn, Netherlands (ots/PRNewswire) - The validation and overall specificity of the Biozek rapid test has 98% for IgG and 96%, for IgM, which is a bench mark for antibody rapid tests. Additional research is currently being conducted in various University hospitals, including the Amsterdam University Medical Center. Globally reliable data was not yet available relevant to antibody levels in mild infections and how the ...
plusForaCare Providing Critical Tools to Help Control COVID-19 Spread / Autonomous Temperature Measurement, Pulse Oximetry, TeleHealth System Help Medical Personnel, Businesses and Patients
plus